News
The Zacks Consensus Estimate for ORCL’s fiscal 2026 earnings is pegged at $6.71 per share, which has remained steady over the ...
Detailed price information for Lexicon Pharmaceutcl (LXRX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback